ARS Pharmaceuticals Logo

ARS Pharmaceuticals

🇺🇸
SPRY
US82835W1080

ARS Pharmaceuticals is a leading U.S.-based biopharmaceutical company focused on innovative therapies for severe allergic reactions. The company specializes in the development of needle-free emergency medications for the treatment of anaphylaxis, utilizing advanced delivery systems to improve patient care.

Next Quarterly Earnings

Tuesday, November 17, 2026
CW 47
After-Hours
In 82 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 20, 2026

Stock Price

Frequently asked questions

When will ARS Pharmaceuticals report its next quarterly earnings?

ARS Pharmaceuticals is scheduled to report its next quarterly earnings on 11/17/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did ARS Pharmaceuticals last report quarterly earnings?

ARS Pharmaceuticals last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -0.63 USD.

How often has ARS Pharmaceuticals beaten expectations?

ARS Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).

How do I add the ARS Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.29
Actual:
Q2 2026
Missed
Estimate:-$0.48
Actual:-$0.63
Difference:-$0.15
Price reaction (1 day):-7.4 %
Q1 2026
Missed
Estimate:-$0.52
Actual:-$0.61
Difference:-$0.09
Price reaction (1 day):-6.5 %
Price reaction (7 days):0.0 %
Q3 2025
Beat
Estimate:-$0.48
Actual:-$0.42
Difference:+$0.06
Q2 2025
Missed
Estimate:-$0.49
Actual:-$0.52
Difference:-$0.03
Q1 2025
Beat
Estimate:-$0.52
Actual:-$0.46
Difference:+$0.05

Earnings statistics

Estimates vs. results

2/5
Quarters above estimates
40%
Beat rate
-10%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
ARS Pharmaceuticals
Ticker Symbol
SPRY
ISIN
US82835W1080
Country
🇺🇸
USA
Sector